Federated Hermes, Inc. Bionano Genomics, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.4 - $25.4 $2 - $50	2 Added 200.0%	3 $0
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $282 - $28,224	-784 Reduced 99.87%	1 $1,000
Q2 2022 Aug 15, 2022	BUY	$12.3 - $27.3 $9,655 - $21,430	785 New	785 $2,000
Q3 2019 Nov 14, 2019	SELL	$6.7 - $11.8 $111,467 - $196,316	-16,637 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	N/A	-7,104,349 Reduced 99.77%	16,637 $0
Q3 2018 Nov 13, 2018	BUY	N/A	7,120,986 New	7,120,986 $56.7 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.